|
Volumn 39, Issue 11, 1998, Pages 1092-1098
|
Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
HYDROCORTISONE;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ADOLESCENT;
ARTICLE;
BURKITT LYMPHOMA;
CHILD;
CLINICAL TRIAL;
FEMALE;
HISTIOCYTIC LYMPHOMA;
HUMAN;
INFANT;
LYMPHOBLASTOMA;
MALE;
MULTICENTER STUDY;
NONHODGKIN LYMPHOMA;
PRESCHOOL CHILD;
REMISSION;
ADOLESCENT;
ANTI-INFLAMMATORY AGENTS;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
BURKITT LYMPHOMA;
CHILD;
CHILD, PRESCHOOL;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HUMANS;
HYDROCORTISONE;
INFANT;
LYMPHOMA, LARGE-CELL;
LYMPHOMA, LYMPHOBLASTIC;
LYMPHOMA, NON-HODGKIN;
MALE;
METHOTREXATE;
PREDNISOLONE;
REMISSION INDUCTION;
VINCRISTINE;
|
EID: 0032196975
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|